Brief Report: VGLL4 Is a Novel Regulator of Survival in Human Embryonic Stem Cells
VGLL4 is a Novel Regulator of Survival in Human Embryonic Stem Cells_Tajonar Melton et al_2013.pdf (522.7Kb)
Access StatusFull text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.
MetadataShow full item record
CitationTajonar, Adriana, René Maehr, Guang Hu, Julie B. Sneddon, José Rivera-Feliciano, Dena E. Cohen, Stephen J. Elledge, and Douglas A. Melton. 2013. “Brief Report: VGLL4 Is a Novel Regulator of Survival in Human Embryonic Stem Cells.” Stem Cells 31 (12) (December): 2833–2841. doi:10.1002/stem.1445. http://dx.doi.org/10.1002/stem.1445.
AbstractHuman embryonic stem cells (hESCs) are maintained in a self-renewing state by an interconnected network of mechanisms that sustain pluripotency, promote proliferation and survival, and prevent differentiation. We sought to find novel genes that could contribute to one or more of these processes using a gain-of-function screen of a large collection of human open reading frames. We identified Vestigial-like 4 (VGLL4), a cotranscriptional regulator with no previously described function in hESCs, as a positive regulator of survival in hESCs. Specifically, VGLL4 overexpression in hESCs significantly decreases cell death in response to dissociation stress. Additionally, VGLL4 overexpression enhances hESC colony formation from single cells. These effects may be attributable, in part, to a decreased activity of initiator and effector caspases observed in the context of VGLL4 overexpression. Additionally, we show an interaction between VGLL4 and the Rho/Rock pathway, previously implicated in hESC survival. This study introduces a novel gain-of-function approach for studying hESC maintenance and presents VGLL4 as a previously undescribed regulator of this process.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:32969833
- FAS Scholarly Articles